This particularly applies to tech giants and popular consumer-facing stocks. What if you'd invested in GoldmanSachs (GS) ten years ago? It may not have been easy to hold on to GS for all that ...
Goldman Sachs has initiated coverage of Vera Therapeutics (NASDAQ:VERA) with a buy rating, citing the potential of its drug candidate atacicept and a recent pullback in the stock. The investment bank ...